Stalfort John A III

Stalfort John A III is listed in filings as Director at Acumen Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including purchase activity. Recent filings connect the profile to Acumen Pharmaceuticals, Inc. (ABOS), Taysha Gene Therapies, Inc. (TSHA), and Verrica Pharmaceuticals Inc. (VRCA). The current snapshot covers public activity from Jun 10, 2024 to Jun 5, 2026. Reported amounts are shown as $121.9K to $20.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.